Immunoglobulin A expression in adult cutaneous leukocytoclastic vasculitis and its effect on hospital outcomes - 10/10/20
Doi : 10.1016/j.jaad.2020.06.062
Kalyn P. Hoffman, MD a, Catherine Chung, MD b, c, Samir Parikh, MD d, Shawn G. Kwatra, MD e, John Trinidad, MD b, Benjamin H. Kaffenberger, MD b, ⁎ 
a The Ohio State University College of Medicine, Columbus, Ohio
b The Ohio State University Wexner Medical Center Division of Dermatology
c The Ohio State University, Wexner Medical Center, Department of Pathology, Columbus, Ohio
d The Ohio State University, Wexner Medical Center, Division of Nephrology, Columbus, Ohio
e Johns Hopkins University Department of Dermatology, Baltimore, Maryland
∗Correspondence to: Benjamin H. Kaffenberger, MD, Ohio State University Medical Center Dermatology, 2012 Kenny Road, 2nd Floor, Columbus, OH, 43212Ohio State University Medical Center Dermatology2012 Kenny Road, 2nd FloorColumbusOH43212
| Funding Sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Approved. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 5
P. 1511-1513 - novembre 2020 Retour au numéro
Article précédent
- Factors associated with insurance coverage of tofacitinib for alopecia areata: A retrospective review from an academic institution
- Hannah J. Thompson, Theresa Vavra, Ali Jabbari
- Gender and racial underrepresentation in academic dermatology positions in the United States: A retrospective, cross-sectional study from 2007 to 2018
- Justin D. Lu, Sabeen Tiwana, Priya Das, Javed Siddiqi, Faisal Khosa
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?